ESR1 and polycystic ovary syndrome: Future studies may further explore the expression patterns of c-Fos in different subtypes of PCOS and its association with metabolic syndrome components such as insulin resistance and inflammatory responses, and develop specific c-Fos inhibitors or ERα agonists to provide new theoretical basis and intervention targets for the precision treatment of PCOS.